Calcium imaging reveals comparable calcium responses and contractions in rat and human sweat glands. by Teresa Franziska Buck (21272954)

RBM39 is methylated by PRMT6 at arginine 92. by Tongjia Zhang (16496661)

Sociodemographic data of the sample. by María García-Arrabé (21156737)

Flowchart of the study. by María García-Arrabé (21156737)

Bandages: KT (3A) and RT (3B). by María García-Arrabé (21156737)

ANOVA repeated measures of the variables. by María García-Arrabé (21156737)

Dataset. by María García-Arrabé (21156737)

CONSORT Flow Diagram. by María García-Arrabé (21156737)

Interpretation of findings of the present study. by Rayane Brinck Teixeira (6676529)

Heatmap analysis for technical reproducibility of Cohort #1 CP dataset (28wk-old WT and R14^Δ/+). by Brian Foo (19273132)

Channel pruning process. by Zhongjian Xie (4633099)

Stepped wedge cluster randomized trial design. by Antonio Marty Quispe (12574259)

Study selection flow diagram. by Laurence Weinberg (2960238)

Diagram of exercise intervention progression. by JoEllen M. Sefton (16880253)

Inclusion and exclusion criteria. by Laurence Weinberg (2960238)

Key characteristics of the included publications. by Laurence Weinberg (2960238)

Parameter description and description. by Zheng Liu (28397)

PERCOM, an unbiased and easily-accessible protein-centric analysis workflow. by Brian Foo (19273132)

EHT treatments evaluated. by Jackline L. Martin (12265386)

“…Overall, Interceptor G2 LLINs induced higher 72-hour mortality compared to standard LLINs of the same age up to12 months (44% vs 21%, OR: 3.5, 95% CI: 1.9–6.6, p-value < 0.001), and 24-hour mortality was only significantly higher in Olyset Plus when new (OR: 13.6, 95%CI: 4.4–41.3, p-value < 0.001) compared to standard LLINs but not at 12 months (17% vs 13%; OR: 2.1, 95% CI: 1.0–4.3; p-value = 0.112). …”

Stata file for the experimental hut data. by Jackline L. Martin (12265386)

“…Overall, Interceptor G2 LLINs induced higher 72-hour mortality compared to standard LLINs of the same age up to12 months (44% vs 21%, OR: 3.5, 95% CI: 1.9–6.6, p-value < 0.001), and 24-hour mortality was only significantly higher in Olyset Plus when new (OR: 13.6, 95%CI: 4.4–41.3, p-value < 0.001) compared to standard LLINs but not at 12 months (17% vs 13%; OR: 2.1, 95% CI: 1.0–4.3; p-value = 0.112). …”